Stock DNA
Pharmaceuticals & Biotechnology
CNY 13,485 Million (Large Cap)
23.00
NA
2.05%
-0.23
13.28%
3.18
Revenue and Profits:
Net Sales:
874 Million
(Quarterly Results - Jun 2026)
Net Profit:
160 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
24.46%
0%
24.46%
6 Months
19.05%
0%
19.05%
1 Year
-6.96%
0%
-6.96%
2 Years
47.41%
0%
47.41%
3 Years
13.64%
0%
13.64%
4 Years
26.64%
0%
26.64%
5 Years
-58.44%
0%
-58.44%
Micro-Tech (Nanjing) Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
17.78%
EBIT Growth (5y)
17.20%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.45
Sales to Capital Employed (avg)
0.71
Tax Ratio
16.77%
Dividend Payout Ratio
49.15%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
24.37%
ROE (avg)
12.38%
Valuation key factors
Factor
Value
P/E Ratio
23
Industry P/E
Price to Book Value
3.09
EV to EBIT
19.30
EV to EBITDA
16.43
EV to Capital Employed
3.73
EV to Sales
3.63
PEG Ratio
NA
Dividend Yield
2.11%
ROCE (Latest)
19.34%
ROE (Latest)
13.28%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ
Jun'26
Mar'26
Change(%)
Net Sales
874.20
853.70
2.40%
Operating Profit (PBDIT) excl Other Income
251.30
205.70
22.17%
Interest
0.30
0.30
Exceptional Items
0.80
0.20
300.00%
Consolidate Net Profit
159.70
148.70
7.40%
Operating Profit Margin (Excl OI)
245.00%
240.90%
0.41%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2026 is 2.40% vs 6.29% in Mar 2026
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2026 is 7.40% vs 183.24% in Mar 2026
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
3,167.00
2,736.80
15.72%
Operating Profit (PBDIT) excl Other Income
740.60
702.50
5.42%
Interest
8.10
11.10
-27.03%
Exceptional Items
-7.00
-5.00
-40.00%
Consolidate Net Profit
582.60
568.10
2.55%
Operating Profit Margin (Excl OI)
188.40%
214.90%
-2.65%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 15.72% vs 14.31% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 2.55% vs 14.84% in Dec 2024
About Micro-Tech (Nanjing) Co., Ltd. 
Micro-Tech (Nanjing) Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






